546 related articles for article (PubMed ID: 22513435)
1. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?
White EC; Melmed GY; Vasiliauskas E; Dubinsky M; Ippoliti A; McGovern D; Targan S; Fleshner P
Dis Colon Rectum; 2012 May; 55(5):563-8. PubMed ID: 22513435
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.
Bafford AC; Powers S; Ha C; Kruse D; Gorfine SR; Chessin DB; Bauer JJ
J Clin Gastroenterol; 2013 Jul; 47(6):491-5. PubMed ID: 23090048
[TBL] [Abstract][Full Text] [Related]
3. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
4. Type and Quantity of Pharmacologic Therapy for Crohn's Disease before Eventual Surgical Treatment.
Kamiński JP; Miraflor E; Zaghiyan K; Fleshner P
Am Surg; 2016 Oct; 82(10):989-991. PubMed ID: 27779990
[TBL] [Abstract][Full Text] [Related]
5. The impact of bacterial DNA translocation on early postoperative outcomes in Crohn's patients undergoing abdominal surgery.
Li Y; Zuo L; Zhu W; Gong J; Zhang W; Gu L; Guo Z; Li N; Li J
J Crohns Colitis; 2015 Mar; 9(3):259-65. PubMed ID: 25555386
[TBL] [Abstract][Full Text] [Related]
6. Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn's disease.
Ahmed Ali U; Martin ST; Rao AD; Kiran RP
Dis Colon Rectum; 2014 May; 57(5):663-74. PubMed ID: 24819109
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting the incidence of early endoscopic recurrence after ileocolonic resection for Crohn's disease: a multicentre observational study.
de Barcelos IF; Kotze PG; Spinelli A; Suzuki Y; Teixeira FV; de Albuquerque IC; Saad-Hossne R; da Silva Kotze LM; Yamamoto T
Colorectal Dis; 2017 Jan; 19(1):O39-O45. PubMed ID: 27943564
[TBL] [Abstract][Full Text] [Related]
8. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.
El-Hussuna A; Andersen J; Bisgaard T; Jess P; Henriksen M; Oehlenschlager J; Thorlacius-Ussing O; Olaison G
Scand J Gastroenterol; 2012 Jun; 47(6):662-8. PubMed ID: 22486168
[TBL] [Abstract][Full Text] [Related]
9. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
Yu CS; Jung SW; Lee JL; Lim SB; Park IJ; Yoon YS; Kim CW; Yang SK; Ye BD; Park SH; Han M; Kim JC
Inflamm Bowel Dis; 2019 Aug; 25(9):1559-1568. PubMed ID: 30753560
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?
Canedo J; Lee SH; Pinto R; Murad-Regadas S; Rosen L; Wexner SD
Colorectal Dis; 2011 Nov; 13(11):1294-8. PubMed ID: 20969715
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
Latella G; Cocco A; Angelucci E; Viscido A; Bacci S; Necozione S; Caprilli R
Dig Liver Dis; 2009 Apr; 41(4):269-76. PubMed ID: 18955023
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of ileocolic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complications.
Mascarenhas C; Nunoo R; Asgeirsson T; Rivera R; Kim D; Hoedema R; Dujovny N; Luchtefeld M; Davis AT; Figg R
Am J Surg; 2012 Mar; 203(3):375-8; discussion 378. PubMed ID: 22364904
[TBL] [Abstract][Full Text] [Related]
13. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
14. The changing face of Crohn's disease: a population-based study of the natural history of Crohn's disease in Örebro, Sweden 1963-2005.
Zhulina Y; Udumyan R; Tysk C; Montgomery S; Halfvarson J
Scand J Gastroenterol; 2016 Mar; 51(3):304-13. PubMed ID: 26448101
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn's disease.
Uchino M; Ikeuchi H; Matsuoka H; Bando T; Ichiki K; Nakajima K; Tomita N; Takesue Y
Dis Colon Rectum; 2013 Oct; 56(10):1156-65. PubMed ID: 24022533
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic approach in patients with recurrent Crohn's disease.
Huang R; Valerian BT; Lee EC
Am Surg; 2012 May; 78(5):595-9. PubMed ID: 22546134
[TBL] [Abstract][Full Text] [Related]
17. The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.
Rosenfeld G; Qian H; Bressler B
J Crohns Colitis; 2013 Dec; 7(11):868-77. PubMed ID: 23466411
[TBL] [Abstract][Full Text] [Related]
18. Quality of life improves within 30 days of surgery for Crohn's disease.
Delaney CP; Kiran RP; Senagore AJ; O'Brien-Ermlich B; Church J; Hull TL; Remzi FH; Fazio VW
J Am Coll Surg; 2003 May; 196(5):714-21. PubMed ID: 12742203
[TBL] [Abstract][Full Text] [Related]
19. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
Myrelid P; Marti-Gallostra M; Ashraf S; Sunde ML; Tholin M; Oresland T; Lovegrove RE; Tøttrup A; Kjaer DW; George BD
Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
[TBL] [Abstract][Full Text] [Related]
20. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
